Multicentre, randomised, parallel group, placebo-controlled, double-blind, study, stratified on tobacco status at enrollment, evaluating during 6 months the efficacy of salmeterol powder for inhalation, 50 μg two times per day for the reduction of thoracic distension in subjects with chronic obstructive pulmonary disease (COPD)

Authors
Category Primary study
Registry of TrialsGSK Study Register
Year 2002
This article has no abstract
Epistemonikos ID: e8a09dea7dd19f634620871c24a78295bca07495
First added on: Nov 15, 2017